Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6005
Delayed Data
As of 10:48am ET
 -0.0314 / -4.97%
Today’s Change
0.32
Today|||52-Week Range
2.93
-15.98%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.63
Today’s open0.64
Day’s range0.57 - 0.64
Volume239,963
Average volume (3 months)336,155
Market cap$14.7M
Dividend yield--
Data as of 10:48am ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...+0.00+0.31%
NDRAENDRA Life Sciences ...0.000.00%
SNGXSoligenix Inc-0.07-3.32%
CURNeuralstem Inc-0.04-2.96%
Data as of 10:49am ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts